Biomaterial Database

Therapy of idiopathic membranous nephropathy. 1987

C Ponticelli, and P Zucchelli, and P Passerini

Divisione di Nefrologia e Dialisi, Ospedale Maggiore, Milano, Italy.

UI	MeSH Term	Description	Entries
D007166	Immunosuppressive Agents	Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging.	Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008775	Methylprednisolone	A PREDNISOLONE derivative with similar anti-inflammatory action.	6-Methylprednisolone,Medrol,Metipred,Urbason,6 Methylprednisolone
D002699	Chlorambucil	A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)	4-(Bis(2-chloroethyl)amino)benzenebutanoic Acid,Amboclorin,CB-1348,Chloraminophene,Chlorbutin,Leukeran,Lympholysin,N,N-Di-(2-chloroethyl)-p-aminophenylbutyric Acid,NSC-3088,CB 1348,CB1348,NSC 3088,NSC3088
D004341	Drug Evaluation	Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals.	Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004359	Drug Therapy, Combination	Therapy with two or more separate preparations given for a combined effect.	Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005921	Glomerulonephritis	Inflammation of the renal glomeruli (KIDNEY GLOMERULUS) that can be classified by the type of glomerular injuries including antibody deposition, complement activation, cellular proliferation, and glomerulosclerosis. These structural and functional abnormalities usually lead to HEMATURIA; PROTEINURIA; HYPERTENSION; and RENAL INSUFFICIENCY.	Bright Disease,Kidney Scarring,Glomerulonephritides,Scarring, Kidney
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000305	Adrenal Cortex Hormones	HORMONES produced by the ADRENAL CORTEX, including both steroid and peptide hormones. The major hormones produced are HYDROCORTISONE and ALDOSTERONE.	Adrenal Cortex Hormone,Corticoid,Corticoids,Corticosteroid,Corticosteroids,Cortex Hormone, Adrenal,Hormone, Adrenal Cortex,Hormones, Adrenal Cortex
D000903	Antibiotics, Antineoplastic	Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms.	Antineoplastic Antibiotics,Cytotoxic Antibiotics,Antibiotics, Cytotoxic

Related Publications

C Ponticelli, and P Zucchelli, and P Passerini

Idiopathic membranous nephropathy.

January 1978, Nephron,

C Ponticelli, and P Zucchelli, and P Passerini

Idiopathic membranous nephropathy.

April 1977, The Quarterly journal of medicine,

C Ponticelli, and P Zucchelli, and P Passerini

[Idiopathic membranous nephropathy].

January 1983, Minerva nefrologica,

C Ponticelli, and P Zucchelli, and P Passerini

Relapsing idiopathic membranous nephropathy.

December 1982, Clinical nephrology,

C Ponticelli, and P Zucchelli, and P Passerini

Editorial: Idiopathic membranous nephropathy.

February 1974, Lancet (London, England),

C Ponticelli, and P Zucchelli, and P Passerini

The natural history and therapy of idiopathic membranous nephropathy.

January 1990, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,

C Ponticelli, and P Zucchelli, and P Passerini

An overview of immunosuppressive therapy in idiopathic membranous nephropathy.

August 2012, Minerva medica,

C Ponticelli, and P Zucchelli, and P Passerini

Treatment of idiopathic membranous nephropathy.

October 2012, Journal of the American Society of Nephrology : JASN,

C Ponticelli, and P Zucchelli, and P Passerini

[Treatment of idiopathic membranous nephropathy].

January 2004, Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia,

C Ponticelli, and P Zucchelli, and P Passerini

Treatment of idiopathic membranous nephropathy.

January 1987, Nephron,